A prospective Study of Treatment for Renal Anemia on Prognosis in Hemodialysis Patients

A prospective Study of Treatment for Renal Anemia on Prognosis in Hemodialysis Patients - TRAP study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000000687

Enrollment

500

Registered

2007-06-01

Start date

2007-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with renal anemia receiving erythropoietin, who have maintained dialysis therapy for over 1 year

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with renal anemia receiving erythropoietin, who have maintained dialysis therapy for over 1 year.

Exclusion criteria

Exclusion criteria: Patients with malignancy, infection or inflammatory diseases.

Design outcomes

Primary

Measure	Time frame
1) Doses of erythropoietin and iron requiring for the maintaince of Hb level>11 g/dl 2) Nutritional state 3) Cardiovascular event 4) Hospitaization 5) Survival rate	—

Secondary

Measure	Time frame
The relationships among Hb, ferritin level and markers of nutritional state (TP, albumin, pre-albumin, T-CHO, H-CHO, TG), and cardiovascular risk factors (MDA, MPO, Hs-CRP, TnT)	—

Countries

Japan

Contacts

Public ContactTakahiro Kuragano

Hyogo College of Medicine Internal Medicine Division of Nephrology and Dialysis

kuragano@hyo-med.ac.jp0798-45-6521

Outcome results